190 related articles for article (PubMed ID: 35941895)
21. Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration.
Lee SH; Hahn ST; Park SH
Cardiovasc Intervent Radiol; 2001; 24(6):368-71. PubMed ID: 11907741
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial Chemoembolization.
Li X; Zhong X; Chen ZH; Wang TT; Ma XK; Xing YF; Wu DH; Dong M; Chen J; Ruan DY; Lin ZX; Wen JY; Wei L; Wu XY; Lin Q
Asian Pac J Cancer Prev; 2015; 16(18):8665-70. PubMed ID: 26745134
[TBL] [Abstract][Full Text] [Related]
23. Preoperatively predicting early response of HCC to TACE using clinical indicators and MRI features.
Li ZW; Ren AH; Yang DW; Xu H; Wei J; Yuan CW; Wang ZC; Yang ZH
BMC Med Imaging; 2022 Oct; 22(1):176. PubMed ID: 36207686
[TBL] [Abstract][Full Text] [Related]
24. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
25. Postsurgical treatment with adjuvant transarterial chemoembolization in patients with hepatitis B-related hepatocellular carcinoma: A strobe-compliant article.
Hu H; Liu R; Long XR; Han XK; Fan J; Yan ZP; Wang JH
Medicine (Baltimore); 2016 Dec; 95(52):e5517. PubMed ID: 28033246
[TBL] [Abstract][Full Text] [Related]
26. A prediction model for overall survival after transarterial chemoembolization for hepatocellular carcinoma invading the hepatic vein or inferior vena cava.
Chu HH; Chun SY; Kim JH; Kim PH; Il Gwon D; Ko HK; Kim N
Eur Radiol; 2021 Jun; 31(6):4232-4242. PubMed ID: 33241523
[TBL] [Abstract][Full Text] [Related]
27. Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety.
Zhang ZS; Li HZ; Ma C; Xiao YD
BMC Cancer; 2019 Nov; 19(1):1162. PubMed ID: 31783814
[TBL] [Abstract][Full Text] [Related]
28. Nomogram for predicting severe abdominal pain after initial conventional transarterial chemoembolisation for hepatocellular carcinoma: a retrospective study.
Qin H; Xiao X; Ya H; Li J; Liang F; Jin H; Liao L; Li Y; Qin J; Yu J; Gu J; Zhou C; Jin M; Miao Y; Li S
Sci Rep; 2023 Dec; 13(1):22397. PubMed ID: 38104191
[TBL] [Abstract][Full Text] [Related]
29. Sequential Use of Transhepatic Arterial Chemoembolization and Bipolar Radiofrequency Ablation in the Clinical Therapy of Hepatocellular Carcinoma.
Liang HY; Guo QY; Sun W; Mao XN; Wen F; Shan M; Zhao G; Wang XH; Lu ZM
Cancer Biother Radiopharm; 2015 Dec; 30(10):427-32. PubMed ID: 26683133
[TBL] [Abstract][Full Text] [Related]
30. [Value of texture analysis in evaluating liver cancer recurrence after transarterial chemoembolization].
Wang R; Yang XY; Wang KY; Wang S; Li Q; Wu JF; Xu HT; Dai Y; Han CP; Xu K; Chen GH
Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):200-204. PubMed ID: 28482407
[No Abstract] [Full Text] [Related]
31. Efficacy and safety analysis of dexamethasone-lipiodol emulsion in prevention of post-embolization syndrome after TACE: a retrospective analysis.
Lu H; Zheng C; Liang B; Xiong B
BMC Gastroenterol; 2021 Jun; 21(1):256. PubMed ID: 34116638
[TBL] [Abstract][Full Text] [Related]
32. 25-OH-vitamin D deficiency identifies poor tumor response in hepatocellular carcinoma treated with transarterial chemoembolization.
Wu YQ; Fan WZ; Xue M; Guo J; Wei JL; Wang Y; Yao W; Zhao Y; Li JP
Clin Transl Oncol; 2020 Jan; 22(1):70-80. PubMed ID: 31183764
[TBL] [Abstract][Full Text] [Related]
33. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy.
Peng JW; Lin GN; Xiao JJ; Jiang XM
Asia Pac J Clin Oncol; 2012 Dec; 8(4):356-61. PubMed ID: 22897940
[TBL] [Abstract][Full Text] [Related]
35. Preoperative Nomogram Incorporating Clinical Factors, Serological Markers and LI-RADS MRI Features to Predict Early Recurrence of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Sheng Y; Wang Q; Liu HF; Chen WH; He ZM; Wang Q
Acad Radiol; 2023 Jul; 30(7):1288-1297. PubMed ID: 36424310
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.
He M; Li Q; Shen J; Tan G; Li Q; Lai J; Wei W; Zhang Y; Zou R; Chen M; Guo R; Shi M
Cancer Med; 2019 Aug; 8(9):4200-4213. PubMed ID: 31207163
[TBL] [Abstract][Full Text] [Related]
37. Short-term reductions in non-protein respiratory quotient and prealbumin can be associated with the long-term deterioration of liver function after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Saito M; Seo Y; Yano Y; Miki A; Yoshida M; Azuma T
J Gastroenterol; 2012 Jun; 47(6):704-14. PubMed ID: 22350695
[TBL] [Abstract][Full Text] [Related]
38. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
39. Initial Experience with Balloon-Occluded Trans-catheter Arterial Chemoembolization (B-TACE) for Hepatocellular Carcinoma.
Maruyama M; Yoshizako T; Nakamura T; Nakamura M; Yoshida R; Kitagaki H
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):359-66. PubMed ID: 26711804
[TBL] [Abstract][Full Text] [Related]
40. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]